Definitive Contract VA24117C0066
Award Date 5/1/17
Potential Completion Date 9/30/21
Potential Value $717K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...
- This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for THRYOSEQUENCE TESTING services. The contract has a ceiling value of $248,145.69 and a period of performance through August 14, 2021. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and...
- This is a federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for the provision of ThyroSeq genomic testing services. The contract, valued at $45,000.00, was awarded on October 1, 2025 by the Veterans Integrated Service Network 6, a civilian agency within the U.S. Department of Veterans Affairs. The contract has an ultimate completion date of September 30, 2030 and is structured as a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing...
- This is a federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for $78,750.00 to provide ThyroSeq genomic testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6. The contract is for the ultimate completion date of September 30, 2026. Cytopath Biopsy Lab Inc. is a for-profit organization...
- This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
- This is a firm fixed price contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 molecular testing services. The contract has a potential value of $395,000.00 and a completion date of December 15, 2020. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next generation genomic...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating as Cblpath, for $72,000.00. The contract is for the delivery of ThyroSeq laboratory tests to determine the malignancy of thyroid nodules in order to support surgical decisions. The contract is not set aside and has a period of performance through August 6, 2026. Cblpath is a for-profit organization specializing in anatomic pathology and molecular diagnostic...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...